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Epithelial myosin light chain kinase (MLCK)-dependent barrier dysfunction con-
tributes to the pathogenesis of inﬂammatory bowel diseases (IBD). We reported
that epithelial GM-CSF–STAT5 signalling is essential for intestinal homeostatic
response to gut injury. However, mechanism, redundancy by STAT5 or cell types
involved remained foggy. We here generated intestinal epithelial cell (IEC)-
speciﬁc STAT5 knockout mice, these mice exhibited a delayed mucosal wound
healing and dysfunctional intestinal barrier characterized by elevated levels of
NF-kB activation and MLCK, and a reduction of zonula occludens expression in
IECs. Deletion of MLCK restored intestinal barrier function in STAT5 knockout
mice,andfacilitatedmucosal woundhealing.Consistently, knockdownofstat5in
IEC monolayers led to increased NF-kB DNA binding to MLCK promoter, myosin
light chain phosphorylation and tight junction (TJ) permeability, which were
potentiated by administration of tumour necrosis factor-a (TNF-a), and pre-
ventedbyconcurrentNF-kBknockdown.Collectively,enterocyteSTAT5signalling
protects against TJ barrier dysfunction and promotes intestinal mucosal wound
healing via an interaction with NF-kB to suppress MLCK. Targeting IEC STAT5
signalling may be a novel therapeutic approach for treating intestinal barrier
dysfunction in IBD.
INTRODUCTION
Inﬂammatory bowel diseases (IBD), Crohn’s disease (CD) and
ulcerative colitis (UC), are believed to be caused by complex
interactions among genetic susceptibility, environmental triggers
and immune-mediated tissue injury leading to chronic relapsing
intestinal inﬂammation (Bouma & Strober, 2003). A balance
between IEC proliferation and apoptosis dynamically maintains
intestinal epithelial cell (IEC) barrier homeostatic function;
however, single cell or highly localized IEC apoptosis alone is
insufﬁcient to cause global barrier dysfunction, leading to IBD
(Clayburgh et al, 2005; Turner, 2009). In contrast, intestinal tight
junction (TJ) barrier dysfunction can accelerate the onset and
severity of colitis, and it has been recognized as a major etiologic
factor in IBD (Hollander et al, 1986; Su et al, 2009).
Activation of actomyosin contraction, as assessed by
phosphorylation of the myosin II regulatory light chain
(MLC), has been implicated in the regulation of TJ permeability
(Clayburgh et al, 2004). MLC phosphorylation can be regulated
by myosin light chain kinase (MLCK) (Wang et al, 2005).
Increased MLCK activity has been identiﬁed in IECs of IBD
patients, and tumour necrosis factor-a (TNF-a) and interferon-g
(IFN-g) induce IEC barrier dysfunction by up-regulating MLCK
expression (Blair et al, 2006; Wang et al, 2005). Long MLCK is
the principal form expressed in IECs, and constitutively active
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barrier dysfunction (Su et al, 2009). More importantly, long
MLCK upregulation is correlated with mucosal inﬂammation
and IBD disease activity (Blair et al, 2006). Conversely,
inhibition or depletion of long MLCK protects mice from
TNF-a-dependent intestinal epithelial MLC phosphorylation,
barrier loss and diarrhea (Clayburgh et al, 2005). Thus,
inducible expression of epithelial long MLCK may be a critical
regulator of TJ barrier function and may underlie IBD
pathogenesis. Identiﬁcation of the mechanism by which
regulation of MLCK activity preserves the TJ barrier may lead
to a new therapeutic intervention for IBD.
Recent genome-wide association studies have shown that
genetic variation in Janus-associated kinase (JAK) 2 contributes
to IBD pathogenesis (Anderson et al, 2011; Barrett et al, 2008;
Ferguson et al, 2010). Several cytokines and growth factors
utilize JAK2 to activate STAT5, which regulates cell speciﬁca-
tion,proliferation,differentiationandsurvival(Hennighausen&
Robinson, 2008). Two members of this family, STAT5a and
STAT5b (collectively referred to as STAT5), share more than
95% homology (Snow et al, 2003). The absence of STAT5a
impairs mammary epithelial adhesion (Miyoshi et al, 2001),
suggesting a possible role for STAT5 in regulating cellular
junction. In addition, we have previously reported that STAT5
activation is reduced in inﬂamed colonic IECs in CD and that the
administration of growth hormone (GH) and neutralization of
TNF-a ameliorates mucosal inﬂammation in experimental
colitis through activation of STAT5 in IECs (Han et al, 2006;
Han et al, 2007). Furthermore, stat5b-deﬁcient mice exhibit
increased susceptibility to experimental colitis (Han et al,
2009a). Although the mechanism remains unclear, these studies
suggest that STAT5 plays a protective role in both intestinal
inﬂammation and barrier homeostatic function.
NF-kB is an important regulator of intestinal homeostatic
growth and inﬂammation (Neurath et al, 1996); however, its
effectsonvariousintestinalcellsaredivergent.DeletionofIKK-g/
NEMO in IECs causes severe spontaneous colitis in mice at a
young age (Nenci et al, 2007). Conversely, NF-kB activation in
immune cell types promotes chronic intestinal inﬂammation in
bothCDandUC(Schreiberetal,1998).InIECs,TNF-a,IF N-gand
interleukin-1b (IL-1b) induce a progressive increase in MLCK
protein expression directly through NF-kB activation, leading to
the increases in TJpermeability (Al-Sadi etal, 2009). Hence, tight
regulation of NF-kB activity is critical in the intestinal mucosa in
order to maintain barrier function during injury.
We have reported that STAT5 maintains colonic barrier
integrity by modulating NF-kB activation (Han et al, 2009a);
however, the subsequent molecular events and the disease
drivers are poorly deﬁned. In our current studies, employing
IEC-speciﬁc STAT5 knockout mice (STAT5
IEC KO) and CA-MLCK
Tg and long MLCK knockout (MLCKKO) mice (Clayburgh et al,
2005; Su et al, 2009), we demonstrate for the ﬁrst time that
enterocyteSTAT5signallingstabilizesZOassemblyandprotects
against IEC barrier dysfunction via an interaction with NF-kBt o
suppress MLCK; a STAT5aNF-kB!MLCK negative feedback
mechanism in IECs regulates IEC TJ barrier function and innate
immune responses to intestinal injury.
RESULTS
Depletion of STAT5 in the IECs predisposes mice to intestinal
injury
By crossing STAT5 ﬂox mice (Cui et al, 2004) with villin-cre
transgenic mice (Supporting information Fig S1A), both stat5a
and stat5b genes were speciﬁcally depleted from IECs by CRE-
mediated recombination (Supporting information Fig S1B). The
STAT5
IEC KO mice had a normal birth rate, weight gain and
intestinal histology similar to littermate STAT5 ﬂox mice
(STAT5
IEC WT) (Fig 1A). We treated STAT5
IEC KO mice with
3% DSS either for 7 days for acute experiments or for 5 days
followed by 5 days of water for recovery studies. The STAT5
IEC
KO mice were more susceptible to acute DSS-induced colitis and
also had much poorer colonic wound healing during the water
recovery phase than STAT5
IEC WT mice (Fig 1A). This worse
healing was characterized by a signiﬁcantly higher histological
score (Fig 1B and C), a slower rate of weight gain (Fig 1D), a
shorter colon length (Fig 1E), and more severe rectal bleeding,
soft stools and worse diarrhea than STAT5
IEC WT mice. To
conﬁrm our ﬁndings, we extended the DSS treatment and water
recovery either for 5-day DSSfollowed by 10-day water recovery
or 7-day DSS followed by 14-day water recovery. We
consistently found that the STAT5
IEC KO mice, followed by
either 10-day water recovery or 14-day water recovery, also
exhibitedmuchpoorercolonicwoundhealingthanSTAT5
IEC WT
mice (Fig 1A and F). The STAT5
IEC KO mice were characterized
by higher histopathological scores (Fig 1F) and slower rate of
weight gain than STAT5
IEC WT mice (Supporting information
Fig S2A). We have reported that STAT5 activation is reduced in
the inﬂamed IECs in CD (Han et al, 2006). Here, we extend
previous ﬁndings and we found in particular that STAT5
activation was dramatically upregulated in the adjacent healthy
crypts in CD (Fig 1G). In accordance with our previous report
(Han et al, 2010), we found the impairment of tyrosine
phosphorylated STAT5 in necrotic and inﬂamed colonic crypts
in the DSS-treated controls. Interestingly, STAT5 activation is
elevated in the proliferating crypt cells (Supporting information
Fig S2B). These ﬁndings suggest a protective or repair
mechanism. To determine whether these phenotypic responses
were limited in colon, we examined whether STAT5
IEC KO mice
also responded to non-steroidal anti-inﬂammatory drug
(NSAID) administration, which induces a speciﬁc ileal injury
inimmune-deﬁcientmice(Hanetal,2009b;Hanetal,2010).We
found that STAT5
IEC KO mice developed severe ileitis (Fig 2A)
with a higher ileal histo-pathology and ulceration scores (Fig 2B
and C). These data suggest that STAT5 signalling in enterocytes
is required for protection against intestinal injury and mucosal
wound healing.
Loss of STAT5 signalling enhances intestinal mucosal adaptive
immune response and delays mucosal repair during
inflammation
We next measured intestinal immune cytokine levels and
inﬂammatory cell inﬁltration. Real-time RT-PCR of colonic
mucosa demonstrated that local mRNA levels of all examined
cytokines, including TNF-a,I F N - g, IL-6, IL-17 and IL-23, were
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IEC WT and STAT5
IEC KO mice under basal
conditions. Similarly, these cytokines were elevated in both
genotypes following 7-days DSS acute injury, with the
exception for reduced levels of IL-10 in STAT5
IEC KO (Fig 3A).
All tested cytokine levels remained signiﬁcantly higher
in STAT5
IEC KO,h o w e v e r ,a sc o m p a r e dt oS T A T 5
IEC WT mice
after a 5-day recovery period (Fig 3A). Importantly,
isolated regulatory T cells (CD4
þCD25
þFoxp3
þ), activated
CD4
þ Tc e l l s( C D 4
þCD44
hiCD62L
lo) and macrophages
(CD4
 CD11C
 CD11b
þF4/80
þ) from mesenteric lymph nodes
(MLN) were also signiﬁcantly higher in STAT5
IEC KO mice in the
recovery group than the recovering STAT5
IEC WT mice, as
measured by ﬂow cytometry (FACS) (Fig 3B, Supporting
information Fig S3A). Consistently, colonic mucosal F4/80
þ
macrophages and Foxp3
þ regulatory T cells were markedly
increasedinSTAT5
IEC KOmicein the recovery group comparedto
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Figure 1. Depletion of STAT5 in the IECs predisposes mice to DSS-induced injury and delays intestinal mucosal wound healing. STAT5
IEC KO mice were
treated with 3% DSS for 7 days, or for 5 days followed by 5 days of water, or for 7 days followed by 14 days of water.
A-F. Disease severity (A), histological score (B,C), weight gain (D), colon length (E) and histological scores during disease recovery (F) were evaluated. Ulcer area is
designated by brackets, DC: distal colon, MC: middle colon. Results were expressed as the mean SEM (n¼10),
 p<0.01 versus DC in the STAT5
IEC WT mice
and
#p<0.01 versus MC in the STAT5
IEC WT mice. Original magnification,  100, bar¼100mm.
G. The paraffin-embedded slides were from 9 healthy controls (CON) and 10 patients with CD. Phospho-tyrosine STAT5 (pSTAT5) was determined by IH in CON,
inflamed crypt in CD (CD), and normal crypts in CD (N-CD). The results were quantitated as pSTAT5 positive colonic IECs per Crypt. Results were expressed as
the mean SEM, original magnification,  400, bar¼100mm.
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IEC WT mice, as shown by immunohisto-
chemistry staining (IH) (Supporting information Fig S3B and C).
Severe intestinal mucosal inﬂammation was characterized by a
larger MLN size (Fig 3C, Supporting information Fig S3D) and a
signiﬁcantly higher amount of bacterial translocation to the MLN
in STAT5
IEC KO mice relative to STAT5
IEC WT mice after a 5-day
recovery (Fig 3D). Therefore, loss of IEC STAT5 deregulates the
protective immune response to gut injury, signiﬁcantly delaying
the intestinal mucosal repair. Together, these data indicate that
enterocyte STAT5 is required for control of intestinal mucosal
immune response and mucosal wound repair.
Depletion of IEC STAT5 enhances NF-kB activation
in response to gut injury
NF-kB activation promotes chronic intestinal inﬂammation in
both CD and UC (Han et al, 2006; Schreiber et al, 1998). Our data
exhibitedthatnuclearlevelsofRelA/p65remainedatsigniﬁcantly
higher levels in the colonic mucosa of STAT5
IEC KO mice than in
littermate controls either under basal conditions or during water
recovery after the cessation of DSS (Fig 4A). In addition, colonic
IkBa expression, an endogenous suppressor of NF-kBa c t i v i t y ,
was consistently and remarkably reduced under basal conditions
or in the water recovery group in STAT5
IEC KO mice compared to
STAT5
IEC WT mice (Fig 4B). Most importantly, our data exhibited
thatdepletionofIECSTAT5inmiceincreasedbasalNF-kBac ti vi ty
in IECs, as determined by the nuclear abundance and phosphory-
lation of RelA/p65 (Fig 4C and D). Together, these data suggest
that there is an interaction between IEC STAT5 and NF-kBi nt h e
regulationofthe intestinal immuneresponsetoinjury.IECSTAT5
could suppress NF-kB nuclear activation by stabilizing IkBa to
ameliorate mucosal inﬂammation (STAT5!IkBaaNF-kB).
Depletion of STAT5 in IECs upregulates MLCK activation,
disrupts zonula occluden (ZO) assembly and leads to
increased TJ permeability
O u rd a t ad e m o n s t r a t e dt h a tS T A T 5
IEC KO mice exhibited a
disrupted intestinal barrier under basal conditions, characterized
by increased para-cellular permeability in both ileum and colon
(Fig 5A). STAT5
IEC KO mice also exhibited an increased focal
colonic IEC apoptosis, as measured by IH analysis of cleaved
Caspase-3, and this was accompanied by a slight increase in
proliferation of IECs (Supporting information Fig S4A and B).
However, low levels ofIEC apoptosis thatare highly localized are
insufﬁcient to cause global and persistent TJ barrier dysfunction,
leading to IBD (Clayburgh et al, 2005; Turner, 2009). To further
understand the molecular basis by which STAT5 signalling
Research Article
Role of STAT5 in gut injury
Figure 2. Depletion of STAT5 in enterocytes increases NSAID ileal injury. STAT5
IEC WT and STAT5
IEC KO mice received PIR in the chow for 2 weeks.
A-C. Disease severity (A), ileal histological score (B) and ileal ulceration score (C) were determined, ulcer area is designated by brackets, results were expressed as
the mean SEM (n¼10),
 p<0.01 versus STAT5
IEC WT/PIR. Original magnification,  100, bar¼100mm.
112  2012 EMBO Molecular Medicine EMBO Mol Med 4, 109–124 www.embomolmed.orgmediates the regulation of IEC barrier function, we thus studied
long MLCK mRNA levels in intestinal mucosa and phosphoryla-
tion of the myosin light chain (pMLC) in IECs, as these factors
havebeenimplicatedaskeyregulatorsofTJpermeability(Turner
et al, 1997). Both quantitative PCR and immunoﬂuorescence (IF)
staining showed that MLCK RNA and pMLC were upregulated in
STAT5 deﬁcient IECs (Fig 5B and C). Protein and RNA were then
isolated from IECs of STAT5
IEC WT and STAT5
IEC KO mice using
either EDTA-based or LCM to determine pMLC levels and TJ
proteins (TJPs) expression. The ratio of pMLC and MLC was
increased in STAT5 deﬁcient IECs (Fig 5D). Immunoblot and
quantitative PCR also demonstrated that ZO-1, -2 and -3, but not
other TJP components, had signiﬁcantly reduced protein and
mRNA levels in STAT5-deﬁcient ileal and colonic IECs compared
to control IECs (Fig 5D and E and Supporting information
Fig S4A). Consistently, IF staining conﬁrmed that among the
various components of TJPs, the distributions of ZO-1, ZO-2 and
-3 were disrupted in IECs in STAT5IEC KO mice (Fig 5F). MLCK
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Figure 3. Loss of STAT5 signalling exaggerates intestinal mucosal adaptive immune response. Mice were treated with 3% DSS for 5 days followed by 5 days
of water.
A. Colonic mucosal RNA was extracted; cytokine levels were quantitated by qPCR.
B. Regulatory T cells, activated T cells and macrophages were determined in MLNs using FACS. Results were expressed as the mean SEM (n¼10).
 p<0.01
versus STAT5
IEC WT/DSS, ^p<0.01 versus STAT5
IEC WT/DSSþwater recovery,
#p<0.01 versus STAT5
IEC WT and STAT5
IEC KO/DSS.
C,D. MLNs were weighed (C), and bacterial translocation in the isolated MLNs (D) was determined in STAT5
IEC WT and STAT5
IEC KO mice by colony-forming
units (CFU). Results were expressed as the mean SEM (n¼10),
 p<0.05 versus STAT5
IEC WT,
#p<0.05 versus STAT5
IEC WT/DSS, ^p<0.05 versus
STAT5
IEC WT/DSSþwater recovery.
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binding region (ABR), MLCK-dependent barrier regulation is
associated with ZO-1 stabilization at the TJ (Marchiando et al,
2010; Yu et al, 2010). We found elevated levels of pMLC and
reduced ZO abundance in STAT5-deﬁcient IECs compared to
STAT5
IEC WT IECs (Fig 5D and Supporting information Fig S5A),
indicating that STAT5 in enterocytes may stabilize ZO assembly
under basal conditions, possibly acting on MLCK activity.
Knockdown of stat5 in IEC monolayers increases MLC
phosphorylation and disrupts TJ, leading to
hyperpermeability in IEC monolayer
To conﬁrm our in vivo studies, we grew HT-29 IEC monolayers
on Transwell ﬁlters and used RNA interference (RNAi) to
achieve approximately 90% knockdown of STAT5 expression
(Fig 6B). We observed that paracellular permeability in 17-day
post-conﬂuent HT-29 cell monolayers, assessed by the apical-to-
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Figure 4. STAT5 in IECs regulates NF-kB activation
in response to gut injury. Mice were treated with
3% DSS for 5 days followed by 5 days of water.
Colonic mucosa was extracted, and NE and CE
recovered.
A,B. p65 nuclear abundance was determined in NE
(A), and IkBa and Ikb were detected in CE (B).
Signal intensity was determined by densito-
metry, results were expressed as the mean
 SEM (n¼5).
 p<0.05 versus STAT5
IEC WT
mice,
#p<0.05 versus STAT5
IEC WT mice in the
water recovery group.
C. IECs were isolated from STAT5
IEC WT and STA-
T5
IEC KO mice, p65 nuclear abundances were
determined by WB.
D. Colon sections were immunostained with
phosphoserine p65 (P-p65) as indicated by
arrows. Results were expressed as average
positive cells per crypt, n¼5, bar¼100mm.
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increased by knocking down STAT5 expression. Transepithelial
electrical resistance (TEER) was reduced in STAT5 knockdown
monolayers (Fig 6A). This reduction was accompanied by an
elevation in pMLC levels as well as a reduction in the levels of
ZO-1, -2 and -3, but not in the levels of other membrane-
associated TJPs (Fig 6B). Of note, knockdown of STAT5 did not
alter cleaved Caspase-3 or the expression of the pro-apoptotic
factor Bax in well-differentiated IEC monolayers (Fig 6B). To
further conﬁrm these ﬁndings, we utilized IF to analyse TJ
distribution in HT-29 monolayers grown on the Transwell
inserts. We found that distribution of ZO-1 and -3 along cell
boundaries was disrupted by STAT5 knockdown (Supporting
information Fig S5B). The distribution of all other TJP
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Figure 5. Depletion of STAT5 in IECs upregulates MLCK activation and disrupts ZO assembly, leading to increased TJ permeability.
A. Colonic and ileal paracellular permeability was determined with everted gut sac in STAT5
IEC WT and STAT5
IEC KO mice.
B. Colonic andilealmucosalRNA wasextracted; longMLCKmRNAlevelswerequantitatedbyqPCR.Results wereexpressed asthemean SEM (n¼10).
 p<0.05
versus STAT5
IEC WT mice.
C. Colonic and ileal frozen sections were immunostained with pMLC (red). Negs are negative controls, n¼5.
D. Ileal IECs were isolated from STAT5
IEC WT and STAT5
IEC KO mice, pMLC and MLC, ZO-1, -2 and -3, JAM-A, claudin-2 and occludin were identified with WB. Signal
intensity was determined by densitometry. MLCK activation was expressed as the ratio of pMLC and MLC. n¼5.
E. Ileal IECs were isolated using LCM, ZO-1, -2 and -3 mRNA levels were determined by qPCR,
 p<0.05 versus STAT5
IEC WT mice, n¼10.
F. Ileal frozen sections were, respectively, immunostained with ZO-1 (green) or ZO-3 (red), n¼5. Insets are the confocal images. Original magnification,  100,
bar¼50mm.
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Accordingly, these ﬁndings demonstrate that STAT5 signalling
plays a non-redundant role in ZO expression and assembly; our
data is consistent with a model that STAT5 may regulate TJ
permeability by modulating MLCK activity to stabilize ZO
assembly under basal conditions (STAT5aMLCK!ZOs).
STAT5 knockdown amplifies proinflammatory cytokine-
induced hyperpermeability in IEC monolayer
NF-kB activation is sufﬁcient to upregulate transcription of
MLCK from the long MLCK promoter, and some evidences
suggest that TJPs (TJPs; occludin, claudin-1 and ZO-1) are
internalized through an NF-kB-dependent pathway (Graham
et al, 2006; Tang et al, 2010). We thus ask whether there is a
transcriptional regulation between NF-kB and STAT5 activation
in MLCK-mediated IEC barrier function that impacts intestinal
immune response to mucosal inﬂammation. To mimic in vivo
inﬂammatory signalling, we combined IFN-g (10ng/ml) with
TNF-a (10ng/ml) to basolaterally stimulate the HT-29 mono-
layers. Cytokine-induced monolayer hyperpermeability was
signiﬁcantly enhanced by STAT5 knockdown compared to
cytokine-treated controls (Fig 7A). We then demonstrated that
NF-kB activity and pMLC levels were consistently increased in
stat5 knockdown HT-29 IEC cell monolayers under baseline
conditions, and were enhanced by IFN-g and TNF-a co-
administration in the presence of stat5 RNAi (Fig 7B and C).
Conversely, IkBa, but not IkBb, was reduced in STAT5
knockdown HT-29 IEC monolayers. This reduction was
potentiated by IFN-g and TNF-a co-administration in the
presence of stat5 RNAi (Fig 7D). We next measured NF-kB
and MLCK promoter activity by Electrophoretic Mobility Shift
Assay (EMSA). Consistently, we found that NF-kB-mediated
transcription as well as DNA binding activity on the NF-kB
binding element from the MLCK promoter was promoted in IEC
monolayers by stat5 RNAi, and was further enhanced in the
cytokine-stimulated monolayers with STAT5 knockdown
(Fig 7E and F). Taken together, STAT5 modulates NF-kB
DNA binding in the MLCK promoter to suppress TNF-a-induced
MLCK transcription; whereas STAT5 deﬁciency in IECs
increases NF-kB-activated MLCK to induce a persistent TJ
barrier dysfunction, resulting in the impairment of intestinal
mucosal wound healing in response to gut injury.
Depletion of long MLCK restores intestinal barrier
dysfunction in STAT5
IEC KO mice, and facilitates the intestinal
mucosal wound healing in response to gut injury
To test whether MLCK mediates IEC barrier dysfunction in
STAT5
IEC KO, we crossed MLCKKO mice with our STAT5 ﬂox
mice, and then depleted IEC STAT5 by crossing these mice with
villin-cre mice(MLCK/STAT5
IEC KO). Wefound thatdepletionof
long MLCK reduced increased IEC para-cellular permeability in
STAT5
IEC KO mice (Fig 8A), suggesting that epithelial MLCK
mediates the STAT5 regulation of TJ permeability and STAT5
suppresses MLCK-dependent barrier dysfunction under basal
conditions. We next tested the role of IEC STAT5 activation in
the protection of epithelial MLCK-induced mucosal injury. To
test this, we used CA-MLCK Tg and MLCKKO mice. During
recovery from DSS-induced colonic injury, CA-MLCK Tg mice
exhibited slower wound healing and repair of intestinal mucosa
than littermate controls as characterized by a signiﬁcantly
higher histological score (Fig 8B and C), more severe rectal
bleeding, slower weight gain, shorter colon length, softer stools,
and worse diarrhea than littermate controls. MLCKKO mice
were apparently protected against DSS-induced colonic injury
either in DSS acute injury or during recovery (Fig 8B and C).
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Figure 6. Knockdown of STAT5 in IEC monolayers increases TJ
permeability.
A. HT-29 IEC monolayers, grown on transwell filters, were interfered with
stat5a, stat5b or stat5a and b (stat5) siRNA. Paracellular permeability was
assessed as apical-to-basolateral flux of FITC dextran (FD-4) clearance and
TEER. Results were expressed as the mean SEM (n¼7). TRANS: trans-
fection reagent only.
 p<0.01 versus CON and TRANS.
B. Total proteins (TP) were extracted from post-confluent HT-29 cell
monolayer, ZO-1, -2 and -3, STAT5, cleaved Caspase-3, E-cadherin, pMLC
and MLC weremeasuredby WB(n¼5). Signal intensity wasdeterminedby
densitometry.
 p<0.01 versus TRANS.
116  2012 EMBO Molecular Medicine EMBO Mol Med 4, 109–124 www.embomolmed.orgMost importantly, STAT5 activation in IECs was abrogated in
CA-MLCK Tg mice following DSS exposure and water recovery
as compared to littermate controls, whereas knockout of long
MLCK apparently restored the activation of STAT5 in IECs in
response to DSS injury (Fig 8D). Taken together, these ﬁndings
suggest that IEC STAT5 is required for control of the intestinal
mucosal immune response and promotion of mucosal wound
repair.
Knockdown of RelA/p65 in IEC monolayers prevents
hyperpermeability induced by interfering with stat5
expression
To further demonstrate that STAT5 regulates NF-kB activity in
IECs, further modulates MLC phosphorylation, we performed a
simultaneous knockdown of STAT5 and RelA/p65 in HT-29
monolayers. We observed that paracellular permeability was
increased in STAT5 knockdown monolayers, but not in HT-29
monolayers following RelA/p65 knock down (Fig 9A). Mono-
layer permeability induced by STAT5 knockdown was further
potentiated by IFN-g (10ng/ml) and TNF-a (10ng/ml) co-
administration, while RelA/p65 knockdown promoted resis-
tance of proinﬂammatory cytokine-induced hyperpermeability
in monolayers (Fig 9A). Surprisingly, STAT5 and RelA/p65
double knockdown rescued the hyperpermeability that was
induced by pro-inﬂammatory cytokines in single STAT5
knockdown monolayers (Fig 9A). Thus, the reduction of NF-
kB may prevent hyperpermeability caused by the loss of STAT5
in IEC monolayers. Furthermore, we consistently found that
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Figure 7. STAT5 Knockdown amplifies pro-inflammatory cytokine-induced hyperpermeability in IEC monolayer. HT-29 IEC monolayers on transwell filters,
with and without stat5 RNAi, were exposed to IFN-g (10ng/ml) induction for 18h and then TNF-a (10ng/ml) stimulation for 12h.
A. Paracellular permeability in HT-29 cell monolayers was assessed as FD4 clearance by the apical-to-basolateral flux of FD4 and TEER. The inset indicated
STAT5 knockdown in the monolayers. Results were expressed as the mean SEM (n¼6).
B-D. HT-29 monolayer was interfered with stat5 siRNA, p65 nuclear abundance (B), pMLC levels in TP (C) and cytosolic IkB a and b levels (D) were assessed in the
presence and absence of IFN-g and TNF-a co-stimulation. Signal intensity was determined by densitometry, results were expressed as the mean SEM
(n¼5).
E,F. DNA binding activity in the NF-kB promoter activity (E) or MLCK promoter containing kB binding sites (F) was analysedwith nuclear extracts by EMSAs. Cold
competition assays were performed by adding unlabeled oligonucleotides in 100-fold molar excess; NF-kB identity was confirmed by specific p65 antibody
(2mg) as indicated, and the arrow represented the shifted bands. The representative result is shown from five repeated experiments.
www.embomolmed.org EMBO Mol Med 4, 109–124  2012 EMBO Molecular Medicine 117STAT5 knockdown increased the levels of pMLC and poten-
tiated cytokine-induced pMLC, which was restored by con-
current RelA/p65 knockdown (Fig 9B). Knockdown of STAT5
and basolateral stimulation with cytokines, however, did not
increase the expression of the pro-apoptotic protein Bax
(Fig 9B). Taken together, STAT5 in enterocytes may negatively
regulate NF-kB activation of MLCK and facilitates the protection
of intestinal hyperpermeability induced by pro-inﬂammatory
cytokines (STAT5aNF-kB!MLCK; Fig 9C).
DISCUSSION
Global depletion of STAT5 predisposes mice to experimental
colitis (Han et al, 2009a), however, the phenotype could be
caused by the defective STAT5 signalling in IEC compartment
and/or sub-epithelial laminarpropria(Yao etal, 2006). Wehave
recently shown that STAT5 in enterocytes is required for GM-
CSF regulation of homeostatic responses to gut injury (Han et al,
2010). Thus, in this study, we investigated whether enterocyte
STAT5 directly regulates intestinal homeostatic responses to
injury. We demonstrated that an IEC-speciﬁc stat5 deletion
increases the susceptibility of these animals to DSS-induced
colitis as well as to NSAID-induced ileal injury in mice (Fig 1B);
STAT5
IEC KO mice with colitis exhibited delayed intestinal
mucosal wound healing (Fig 1C), as characterized by sig-
niﬁcantly higher levels of colonic mucosal inﬂammatory cells,
Th1 and Th17 cytokines and NF-kB activation in STAT5
IEC KO
mice as compared to STAT5
IEC WT mice after a 5-day recovery
period. Consistently, the extended time of DSS treatment and
recovery resulted in the worse mucosal injury and poorer
healing in STAT5
IEC KO mice (Fig 1F). These extra time points
excluded the possibility that it is a particular kinetic of recovery
which could affect the mucosal physiology and wound healing
in response to gut injury. Accordingly, enterocyte STAT5 is
requiredforintestinalmucosalwoundhealinginresponsetogut
injury.
TNF-a, IFN-g and IL-1b induce NF-kB activation in the well-
differentiated IECs, leading to a progressive increase in MLCK
protein expression. This process has been postulated to be an
important mechanism that contributes to intestinal inﬂamma-
tion (Al-Sadi et al, 2009; Turner, 2009). Epithelial-speciﬁc IkBa
mutant transgenic mice exhibit attenuated T cell-induced
diarrhea and abrogated increased paracellular permeability
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Figure 8. Depletion of long MLCK restores
intestinal barrier dysfunction in STAT5
IEC KO mice,
and facilitates the intestinal mucosal wound
healing in response to gut injury.
A. Ileal paracellular permeability was determined
with everted gut sac in MLCK/STAT5
IEC KO mice,
results were expressed as the mean SEM
(n¼7). CA-MLCK, MLCK KO and littermate
control mice (CON) were treated with 3% DSS
for either 7 days or for 5 days followed by
5 days of water.
B-D. Disease severity (B) and histological scores
(C) were evaluated. Ulcer area is designated by
brackets, results were expressed as the
mean SEM, n¼10. (D) pSTAT5 was deter-
mined by IF in CA-MLCK Tg, MLCKKO and
littermate control mice exposure to 5 days DSS
followed by 5 days of water, n¼7.
E. IECs were isolated from CA-MLCK Tg, MLCKKO
and littermate control mice and NE extracted.
pSTAT5 nuclear abundance was determined by
WB in NE. Signal intensity was determined by
densitometry, results were expressed as the
mean SEM, n¼5.
 p<0.01 versus controls.
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of NF-kB in IECs controls the expression of many inﬂammatory
cytokines involved in the pathogenesis of IBD. In normal
mammary gland development and differentiation, NF-kB
regulates the milk protein gene b-casein by negatively
interfering with STAT5 tyrosine phosphorylation (Geymayer
& Doppler, 2000). Conversely, we reported that STAT5
signalling antagonize NF-kB binding activity to regulate
epithelial survival (Han et al, 2006; Han et al, 2009a). Our
current studies showed that depletion of STAT5 in IECs resulted
in reduction of IkBa cytosolic abundance, upregulation of NF-
kB nuclear activation and delayed mucosal wound healing.
Interestingly, consistent with the recent report (Smyth et al,
2011), we found thatcombination of IFN-gand TNF-a increased
STAT5 nuclear abundance in HT-29 monolayers (Supporting
information Fig S5C). We think that simultaneous up-regulation
of STAT5 also reﬂects a feed-back response by IEC monolayer
during injury; in other words, the up-regulated STAT5 plays a
protective role in the monolayer TJ disintegration induced by
cytokine-mediated NFkB and MLCK activation. Together, these
data support an interactive regulation between the STAT5 and
NF-kB pathways, and this interaction may impact IEC barrier
function and regulate mucosal wound repair (Fig 9C).
The disrupted IEC barrier has been proposed to play a critical
role in initiating disease through broadly activating mucosal
immune responses and accelerating the onset and severity of
immune-mediated colitis (Blair et al, 2006; Su et al, 2009), for
instance, genetic ablation of IL-10 increases small bowel para-
cellular permeability, leading to the spontaneous colitis in mice
(Madsenetal,1999).Conversely, preservationoftheintegrityof
the IEC barrier may promote intestinal mucosal healing in IBD
(Dignass, 2001). In our studies, STAT5
IEC KO mice exhibited IEC
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Figure 9. Knockdown of RelA/p65 in IEC monolayers rescues hyperpermeability induced by interfering with stat5 expression.
A. HT-29 IEC monolayers, grown on Transwell filters, were interfered with RelA/p65 and/or stat5a and b (stat5) siRNA and exposed to IFN-g (10ng/ml) induction
for 18h and then stimulation with TNF-a (10ng/ml) for 12h. Para-cellular permeability in monolayers was assessed as FD-4 clearance and TEER.
B. Total proteins (TP) were extracted, P-p65, p65, pMLC, MLC and Bax were determined by WB. Results were expressed as the mean SEM (n¼6). ^p<0.01
versus Controls (transfection reagent only),
 p<0.05 versus cytokine-treated controls,
&p<0.05 versus STAT5 knockdown monolayer.
#p<0.01 versus
cytokine-treated STAT5 knockdown monolayer.
C. STAT5 signalling in the IEC barrier function and mucosal injury. STAT5aMLCK!ZOs feedback mechanism stabilizes IEC TJ barrier function under basal
conditions(1);STAT5aNFkB!MLCKnegativefeedbackloopregulatesIECbarrierfunctionunderinflammatoryconditions(2)andmucosal immuneresponses
to gut injury (3). MA, membrane-associated TJPs.
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signiﬁcantly elevated paracellular permeability, focal colonic
IEC apoptosis, and slightly increased proliferation; however,
knockdown of STAT5 in well-differentiated IEC monolayers did
not increase apoptosis under basal conditions. In patients with
active IBD, increased IEC apoptosis, erosions and ulcer-type
lesions contribute to focal barrier defects. In contrast,
morphological breakage and loss of TJ strands are associated
with the global barrier defects seen in active IBD (Schulzke et al,
2009; Zeissig et al, 2007). Ultrastructural analyses conﬁrmed
that the bulk of the transmucosal transport occurred across TJ
ratherthanviagrossepithelialdefects,suchasulcers(Machen&
Erlij, 1972; Shen et al, 2010). Therefore, the IEC apoptosis in
STAT5
IEC KO mice may be secondary to up-regulated proin-
ﬂammatory cytokines caused by IEC TJ barrier disruption,
inﬁltrated luminal bacteria, and sequentially activated adaptive
immune reaction.
Furthermore, our data demonstrated that NF-kBa c t i v a t i o n ,
MLCK mRNA levels and phosphorylation of MLC were
upregulated, and that TJ assembly was disrupted in STAT5
IEC
KO mice. Among the various components of TJ, ZO-1, -2 and -3
exhibited reduced protein and RNA levels as well as a disrupted
distribution. Knockdown of STAT5 activated NF-kB, elevated
pMLC levels and reduced ZO abundance, causing monolayer
hyperpermeability.ZO-1,-2and-3havebeenshowntolocalizeto
theadherensjunction(AJ)withcadherinandcateninspriortothe
localizationofothermembrane-associatedTJPs,suchasoccludin
(Mitic & Anderson, 1998). ZO proteins regulate both AJ and TJ
function by directly binding to F-actin (Yamazaki et al, 2008).
Depletion of both ZO-1 and -2 in the EpH4 mammary epithelial
celllinecompletelyabrogatesTJassemblyandgeneticdeletionof
ZO genes results in embryonic lethality (Xu et al, 2008). More
importantly, MLCK may regulate TJ barrier function by directly
mediating ZO-1 exchange and anchoring (Yu et al, 2010), and
MLC phosphorylation caused ZO-1 redistribution, which can be
reversed by MLCK inhibition (Shen & Turner, 2006). Thus, ZO
proteins may play a key role in directing the regulation of TJ
assembly. We speculate that STAT5 controls TJ integrity by
regulating MLCK-dependent ZO assembly or by direct interaction
with ZO proteins; however, our data do not reveal a direct
interaction between TJ assembly and STAT5 activity. Taken
together, these ﬁndings show that STAT5 signalling plays a non-
redundant role in ZO expression and assembly.
A constitutively active truncated MLCK (tMLCK)-mediated
MLC phosphorylation is sufﬁcient to trigger regulation of TJ
barrier function and ZO-1 redistribution in IEC monolayers
(Shen et al, 2006). We found that long form MLCK expression as
well as pMLC was elevated in STAT5 deﬁcient and knockdown
IEC monolayers under basal conditions, and STAT5 regulated
MLCK promoter activity. Conversely, depletion of long MLCK
reduced increased IEC para-cellular permeability in STAT5
IEC KO
mice. Thus, we speculate that STAT5 controls TJ assembly
under basalconditions,partially by regulating MLCK-dependent
ZO assembly (STAT5aMLCK!ZOs). We found that, during
water recovery, CA-MLCK Tg mice exhibited slower wound
healing and repair of intestinal mucosa than littermate controls.
Conversely, MLCK KO mice were resistant to DSS-induced
mucosal injury. Importantly, STAT5 activation in IECs was
abrogated in CA-MLCK Tg mice and restored in long form MLCK
KO mice following DSS exposure compared to littermate
controls. Therefore, the impaired STAT5 signalling in IECs
delayed intestinal epithelial wound healing, and IEC STAT5
signalling is required for repairing mucosal wound induced by
loss of IEC barrier. However, our data also suggest that other
factors could contribute to the maintenance of increased IEC TJ
permeability during mucosal inﬂammation. The on-going
studies with an extension of mouse genotypes will further
determine the other factors involved in the intestinal pheno-
types due to loss of epithelial STAT5.
To deﬁnitively demonstrate that STAT5 regulates NF-kB
activity in IECs, we simultaneously knocked down STAT5 and
RelA/p65 in HT-29 IEC monolayers and stimulated IEC
monolayers with the combination of IFN-g and TNF-a (Wang
et al, 2006). We observed that knockdown of RelA/p65
prevented the upregulated MLC phosphorylation and TJ
hyperpermeability in IEC monolayers, which were induced by
either STAT5 knockdown or proinﬂammatory cytokine admin-
istration. Most importantly, we found that loss of STAT5
enhanced the NF-kB and MLCK promoter activity in response to
cytokine administration, and that STAT5 antagonizes NF-kB
DNA binding in long MLCK promoter. Accordingly, IEC STAT5
may negatively regulate NF-kB activation of MLCK to modulate
MLCphosphorylation(STAT5aNFkB!MLCK),whichprotects
IEC barrier function to promote IEC wound healing (Fig 9C).
Taken together, our ﬁndings suggest that a novel negative
feedback mechanism (STAT5aNFkB!MLCK) directly regu-
lates intestinal epithelial TJ barrier function and immune
responses to injury relevant to human IBD (Fig 9C). Our results
demonstrate the regulation of epithelial STAT5 activity as a
means to improve IEC barrier dysfunction and mucosal
inﬂammation in IBD. Thus, these studies will provide a
potential therapeutic target for treating intestinal barrier
dysfunction and mucosal wound healing in IBD.
MATERIALS AND METHODS
Materials
All chemicals and antibodies were purchased from Sigma–Aldrich
(St. Louis, MO) unless otherwise noted. Antibodies specific for MLC and
phosphorylated MLC (serine 19) (pMLC), phospho-tyrosin694 specific
STAT5 (pSTAT5), phospho-serine276 p65 (P-p65) antibodies were from
Cell Signaling Technology (Danvers, MA). Antibodies specific for STAT5a
and STAT5b were from Zymed Laboratories (South San Francisco, CA).
Antibodies specific for STAT5, p65, p50, Bax and IkBa and b were from
Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies specific for
ZO-1, -2 and -3, occludin, JAM-A, claudin 1 and 2 were from
Invitrogen (Carlsbad, CA). Another tyrosine (Y694/699) phosphoryla-
tion specific STAT5 antibody was from Upstate Biotechnology (Lake
Placid, NY). CD4, CD25 and Foxp3 were from eBioscience (San Diego,
CA). Antibodies specific for CD3, CD44, CD62L, CD11b and F4/80
were from BD Pharmingen (San Jose, CA). ON-TARGET plus SMARTpool
for human stat5 a and b and RelA/p65 were purchased from
DHARMACON (Lafayette, CO).
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controls and pediatric CD; the de-identified patient-based studies
were approved by the CCHMC IRB (# 2009-1680).
Animal resources and maintenance
The animal study protocol has been approved by the CHRF
Institutional Animal Care and Use Committee (IACUC). Breeding pairs
for CA-MLCK Tg mice and MLCKKO mice have been obtained from
Dr. Turner’s laboratory at University of Chicago (Su et al, 2009).
Breeding pairs of STAT5 floxed mice (STAT5
F/F)w e r ef r o m
Dr. Hennighausen’s lab at NIDDK (Cui et al, 2004). C57BL/6 mice
and Villin-Cre transgenic mice (B6.SJL-Tg) were ordered from Jackson
Labs (Bar Harbor, MA). Deletion of STAT5 from intestinal epithelia was
achieved by breeding STAT5
F/F mice with villin-Cre transgenics. All
mice used in these studies have been backcrossed with C57BL/6 for
more than 10 generations and were re-genotyped with respect to
STAT5 and Cre following necropsy. All studies were performed
with littermate STAT5
F/F mice designated as wild-type controls
(STAT5
IEC WT), and STAT5
F/F, villin-Cre animals denoted as STAT5
IEC KO.
MLCKKO mice were crossed with our STAT5
F/F mice, and then depleted
IEC STAT5 by crossing these mice with villin-cre mice, these mice were
denoted as MLCK/STAT5
IEC KO. Mice were maintained in specific
pathogen free (SPF) conditions in the Children’s Hospital Research
Foundation (CHRF) Animal Care Facility.
Animal model of colitis
Intestinal inflammation was induced by providing transgenic or
control littermate mice with 3% dextran sulphate sodium (DSS) water
(m.w. 36,000–50,000; MP Biomedicals) for either 7 days for acute
studies or 5 days followed by 5 days of water for healing phase
studies. Mice were sacrificed; the colon was removed, and dissected
into three equal fragments: distal, middle and proximal colon. For each
colon fragment, longitudinal cuts of tissue in which the three colon
sections had clearly visible intestinal lumen were used in histological
scoring with the observer blinded to genotype. Scoring parameters
included quantitation of the area of middle and distal colon involved,
edema, erosion/ulceration of the epithelial monolayer, crypt loss/
damage and infiltration of immune cells into the mucosa.Total disease
score was expressed as the mean of all combined scores per genotype
(Steinbrecher et al, 2008).
Animal model of ileitis
To establish the animal model of ileitis, 5- or 6-week old male and
female STAT5
IEC KO and STAT5
IEC WT mice were exposed to a NSAID,
piroxicam (PIR), at 200ppm in the chow for 2 weeks. Control mice
continued on regular chow. Mice were then sacrificed following PIR
exposure to determine effects upon the development of ileitis, and
histology was scored as published (Han et al, 2010).
Measurement of paracellular intestinal permeability and
bacterial translocation
Ileal and colonic paracellular permeability to the fluorescent tracer
fluorescein isothiocyanate-dextran with a molecular mass of 4kDa
(FD-4) was determined using an everted gut sac method (Han et al,
2010). Fluorescence was measured using a fluorescence spectro-
photometer (Biotek Instruments, VT) at an excitation wavelength of
492 and an emission wavelength of 515nm. Permeability was
expressed as the mucosal-to-serosal clearance of FD-4. Bacterial
translocation to MLN was determined as described (Han et al, 2010).
Western blot (WB), Electrophoretic Mobility Shift Assay (EMSA),
immunohistochemistry (IH) and immunofluorescence (IF)
Isolated colonic and ileal IECs, and mucosal tissue were saved. Total
cellular protein (TP), cytosolic protein (CE) and nuclear protein (NE)
extracts were prepared using cold RIPA buffer and the NE-PER kit per
the manufacturers’ recommendations (Pierce, Rockford, IL). Expression
of ZO-1, -2 and -3, occludin, claudin 1 and 2, junction adhesion
molecule (JAM)-A, STAT5, MLC and pMLC abundance were detected in
TP from the isolated IECs. The nuclear abundance of pSTAT5, pSTAT3
and p65 was detected in NE. IkBa and b were determined in CE. Band
intensities were quantified as mean area density using ImageQuant
(Molecular Dynamics, Sunnyvale, CA). pMLC was expressed as relative
area density corrected by MLC bands intensity. One microgram NE was
used for EMSAs. NF-kB DNA binding was performed using a duplex
oligonucleotide probe containing the consensus NF-kBb i n d i n g
sequence (Han et al, 2009a; Ma et al, 2004). MLCK promoter activity
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The paper explained
PROBLEM:
Dysregulatedintestinalbarrierfunctionisacriticalcomponentof
the pathogenesis of inflammatory bowel diseases (IBD). Recent
genome-wide association studies (GWAS) have implicated
that JAK STAT signalling is involved in IBD pathogenesis.
Mechanisticstudiesare now requiredto define functional effects
of these pathways.
RESULTS:
Our studies defined for the first time STAT5 target genes
regulating TJ barrier function, and determined whether a novel
negative feedback mechanism (STAT5aNF-kB!MLCK) directly
regulates IEC barrier function and response to injury relevant
to human IBD.
IMPACT:
Ourstudiesareexpectedtorevealanovelmechanismofintestinal
barrier dysfunction in IBD, providing a possible approach to
promote intestinal mucosal wound healing. Targeting exploration
of the STAT5aNFkB!MLCK signalling pathways in regulation of
IEC barrier function will enhance not only the understanding of
mucosal innate immunity, but also provide a novel therapeutic
target for treatment of epithelial barrier dysfunction in IBD.
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on the downstream NFkB-binding element in the MLCK promoter
region (Ye et al, 2006). DNA binding was detected according to
LightShift chemiluminescent EMSA kit (Pierce, Rockford, IL) (Han et al,
2006). The sequences of the oligonucleotide probe are listed in the
Supporting information Table. Frozen tissue sections from mouse ileum
and colon (4mm) were prefixed in paraformaldehyde. Tissue sections
were labelled with ZO-1, -2 and -3, pMLC and pSTAT5 following FITC-
conjugated or TRITC-conjugated goat anti-rabbit secondary antibodies,
40,6-diamidino-2-phenylindole dihydrochloride (DAPI) were used for
nuclear counterstaining. pSTAT5 (phosphotyrosine) and p65 (phospho-
serine 276) were examined in paraffin embedded intestinal sections
using VECTASTAIN Elite ABC system (Vector lab, Burlingame, CA). BrdU
staining followed manufacturer’s instructions (BrdU In Situ Detection
Kit, BD Pharmingen) (Han et al, 2010). BrdU, cleaved Caspase-3,
pSTAT5 and p65 positive cells were counted by a semi-quantitative
method and expressed as average positive cells per crypt. Images were
captured using a Zeiss microscope and Axioviewer image analysis
software (Carl Zeiss Corp, Germany) (Han et al, 2009a).
Flow cytometry (FACS)
Fresh single cell suspensions were prepared from MLN. Cells were stained
for surface markers anti-mouse CD11c, CD11b, F4/80, CD4, CD25, CD44,
CD62L, CD3 or intracellular staining for anti-mouse Foxp3.
The fluorescent signals were measured by FACS (LSR II, BD Biosciences).
Data were analysed using FlowJo software (Tree Star, OR) (Han et al,
2009a).
Laser capture microdissection (LCM)
Briefly, approximately 200 crypts and adjacent surface epithelial cells
from ileum were captured by a Veritas Microdissection System (Life
Technologies, Carlsbad, CA); RNA was isolated with a PicoPure RNA
Isolation kit (Arcturus) using published methods (Han et al, 2006; Han
et al, 2011). The quality and concentration of RNA were measured by
NanoDrop (Thermo Fisher). Total RNA (200ng) was used to reversely
transcribe to cDNA followed by a SYBR Green real-time PCR on the
Mx4000 multiplex quantitative PCR instrument (Stratagene).
Real-time quantitative PCR (qPCR)
Total RNA was isolated from frozen tissue using RNeasy Mini Kit
(QIAGEN,Valencia, CA) according to the manufacturer’s protocol. Using
specific gene primers (ZO-1, -2 and -3, occludin, and GAPDH), PCR
reactions were performed with Brilliant II SYBR Green QPCR mix
(Stratagene, La Jolla, CA) in the Mx3000p thermocycler (Stratagene). A
relative amount for each gene examined was obtained from a
standard curve generated by plotting the cycle threshold value against
the concentration of a serially diluted RNA sample expressing the gene
of interest. This amount was normalized to the level of b-actin or
GAPDH RNA. The primer sequences are listed in the Supporting
information Table followed by references.
RNA interference (RNAi) and IEC monolayer permeability
assay (Han et al, 2003; Wang et al, 2005)
STAT5 a and b and RelA/p65 ON-TARGETplus SMARTpool transfection
was performed with pre-confluent HT-29cells (ATCC, passage 35–45)
growing on Transwell inserts (Becton Dickinson, Bedford, MA). Groups
with transfection reagents only (TRAN) were chosen as controls
for RNAi. For subsequent experiments we used 17-day postconfluent
HT-29 monolayers. The medium bathing the apical surface of the
monolayers was replaced with 200ml of DMEM complete medium
containing FITC-Dextran (FD4, Sigma) at 25mg/ml. The medium
bathing the basolateral side of the monolayers was replaced with
500ml of DMEM complete medium alone or DMEM supplemented
with or without IFN-g (10ng/ml) induction for 18h and then
stimulation with TNF-a (10ng/ml) for 12h. Fluorescence in baso-
lateral bathing medium was measured using a fluorescence spectro-
photometer (Biotek Instruments, VT). The permeability of the
monolayer was expressed as a clearance (C; nlcm
 2h
 1). TEER was
measured by E-VOM instrument (World Precision Instruments,
Sarasota, FL). Results were expressed as Ohmcm
2.
Statistical analysis
Results are presented as the mean SEM. Data were analysed using
analysis of variance, two-tailed Student’s t-test, and the Mann–
Whitney test as appropriate (Prism, GraphPad, San Diego, CA). p-
values 0.05 were considered significant.
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